This is far better than I expected. They said they would possibly exceed full year guidance, and they are on track to do it easily.
If we times half year results by 2 (and exclude quarterly growth) we have: Revenue = 138.63m (up 2.7% on guidance) EBITDA = 33.43m (up 2.9% on guidance) Underlying NPAT = 16.04m (up 10.6% on guidance)
There will likely be quarter on quarter growth so this is conservative.
Wasn't expecting that much statutory NPAT. I will crunch some numbers below: NPAT: 14.706m SOI: 254.155m EPS = 0.0579 PE ratio: 15
Share price = 87 cents
I think a PE ratio of 15 is realistic. ACF were sitting around 15 PE in 2019. Since then PE has been in the 20s and 30s.
It could be a good 6 month for shareholders. Bring on that interim dividend
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)